Rheumatoid arthritis trials recruiting in Florida
All Rheumatoid arthritis trials nationally
30
Recruiting in Florida
40
Cities with sites
Cities in Florida
Clearwater 9Miami 9Tampa 8Gainesville 5Jacksonville 5Plantation 5South Miami 5Margate 4Orlando 4Hialeah 3Avon Park 2Cooper City 2
Recruiting trials in Florida
- A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
- A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
- Exactech Shoulder Post Market Clinical Follow-up Study
- Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
- Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
- Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
- Phase 1b/2 Study of IV Sarilumab in Adult With RA
- Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Physica System Total Knee Replacement Registry Study
- R-2487 in Patients With Rheumatoid Arthritis
- RA-PRO PRAGMATIC TRIAL
- Rheumatology Diet Study
- Study of GS-0151 in Participants With Rheumatoid Arthritis
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden